BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Diagnosis
27 results:

  • 1. Cumulative incidence of second primary cancers in a large nationwide cohort of Danish cancer survivors: a population-based retrospective cohort study.
    Kjaer TK; Andersen EAW; Ursin G; Larsen SB; Bidstrup PE; Winther JF; Borre M; Johansen C; Dalton SO
    Lancet Oncol; 2024 Jan; 25(1):126-136. PubMed ID: 38048803
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development of machine learning prognostic models for overall survival of prostate cancer patients with lymph node-positive.
    Peng ZH; Tian JH; Chen BH; Zhou HB; Bi H; He MX; Li MR; Zheng XY; Wang YW; Chong T; Li ZL
    Sci Rep; 2023 Oct; 13(1):18424. PubMed ID: 37891423
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
    Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
    World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long-term Recurrence Rates of Low-risk Non-muscle-invasive Bladder cancer-How Long Is Cystoscopic Surveillance Necessary?
    Ma J; Roumiguie M; Hayashi T; Kohada Y; Zlotta AR; Lévy S; Matsumoto T; Sano T; Black PC
    Eur Urol Focus; 2024 Jan; 10(1):189-196. PubMed ID: 37442722
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
    Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
    [No Abstract]    [Full Text] [Related]  

  • 6. Mapping the Patient-Oriented prostate Utility Scale From the Expanded prostate cancer Index Composite and the Short-Form Health Surveys.
    Zamora V; Garin O; Pardo Y; Pont À; Gutiérrez C; Cabrera P; Gómez-Veiga F; Pijoan JI; Litwin MS; Ferrer M;
    Value Health; 2021 Nov; 24(11):1676-1685. PubMed ID: 34711369
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. National cancer Information System Within the Framework of Health Insurance in Colombia: A Real-World Data Approach to Evaluate Access to cancer Care.
    Hernández Vargas JA; Ramírez Barbosa PX; Valbuena-Garcia AM; Acuña-Merchán LA; González-Diaz JA; Lopes G
    JCO Glob Oncol; 2021 Aug; 7():1329-1340. PubMed ID: 34473526
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Improving Global Surgical Oncology Benchmarks: Defining the Unmet Need for cancer Surgery in Ghana.
    Gaskill CE; Gyedu A; Stewart B; Quansah R; Donkor P; Mock C
    World J Surg; 2021 Sep; 45(9):2661-2669. PubMed ID: 34152449
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. mpMRI of the prostate (MR-Prostatography): Updated Recommendations of the DRG and BDR on Patient Preparation and Scanning Protocol.
    Franiel T; Asbach P; Beyersdorff D; Blondin D; Kaufmann S; Mueller-Lisse UG; Quentin M; Rödel S; Röthke M; Schlemmer HP; Schimmöller L; ;
    Rofo; 2021 Jul; 193(7):763-777. PubMed ID: 33735931
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. cancer Stage, Treatment, and Survival Among Transgender Patients in the United States.
    Jackson SS; Han X; Mao Z; Nogueira L; Suneja G; Jemal A; Shiels MS
    J Natl Cancer Inst; 2021 Sep; 113(9):1221-1227. PubMed ID: 33704460
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Incidence of bone metastases in patients with organ-specific cancers: A nationwide population-based cohort study.
    Shih JT; Yeh TT; Wang SH; Shen PH; Wang CC; Chien WC; Chung CH; Wu CC
    Int J Clin Pract; 2021 May; 75(5):e13997. PubMed ID: 33400307
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Estimating the Cost of Illness of prostate cancer in Iran.
    Mojahedian MM; Toroski M; Keshavarz K; Aghili M; Zeyghami S; Nikfar S
    Clin Ther; 2019 Jan; 41(1):50-58. PubMed ID: 30545740
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
    Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Fat Intake and Risk of Skin cancer in U.S. Adults.
    Park MK; Li WQ; Qureshi AA; Cho E
    Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):776-782. PubMed ID: 29636341
    [No Abstract]    [Full Text] [Related]  

  • 15. Quality of life in differentiated thyroid cancer.
    McIntyre C; Jacques T; Palazzo F; Farnell K; Tolley N
    Int J Surg; 2018 Feb; 50():133-136. PubMed ID: 29288117
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Presence and severity of lower urinary tract symptoms are inversely correlated with the risk of prostate cancer on prostate biopsy.
    Cicione A; Cormio L; Cantiello F; Palumbo IM; DE Nunzio C; Lima E; Ucciero G; Carrieri G; Damiano R
    Minerva Urol Nefrol; 2017 Oct; 69(5):486-492. PubMed ID: 28124868
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Validation of Novel Biomarkers for prostate cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.
    Alinezhad S; Väänänen RM; Mattsson J; Li Y; Tallgrén T; Tong Ochoa N; Bjartell A; Åkerfelt M; Taimen P; Boström PJ; Pettersson K; Nees M
    PLoS One; 2016; 11(5):e0155901. PubMed ID: 27196083
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. cancer risk among the HIV-infected elderly in the United States.
    Yanik EL; Katki HA; Engels EA
    AIDS; 2016 Jun; 30(10):1663-8. PubMed ID: 26950314
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer.
    Uemura K; Miyoshi Y; Kawahara T; Yoneyama S; Hattori Y; Teranishi J; Kondo K; Moriyama M; Takebayashi S; Yokomizo Y; Yao M; Uemura H; Noguchi K
    BMC Cancer; 2016 Feb; 16():109. PubMed ID: 26883015
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people.
    Zhang Y; Li P; Xu A; Chen J; Ma C; Sakai A; Xie L; Wang L; Na Y; Kaku H; Xu P; Jin Z; Li X; Guo K; Shen H; Zheng S; Kumon H; Liu C; Huang P
    Tumour Biol; 2016 May; 37(5):6653-9. PubMed ID: 26646562
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.